Terry M. Rich - 15 Feb 2022 Form 4 Insider Report for SURGALIGN HOLDINGS, INC.

Role
President and CEO, Director
Signature
by Jessica Rumschlag as attorney in fact
Issuer symbol
N/A
Transactions as of
15 Feb 2022
Net transactions value
+$199,946
Form type
4
Filing time
16 Feb 2022, 10:43:16 UTC
Previous filing
13 Aug 2021
Next filing
17 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRGA Common Stock Purchase $199,914 +434,784 +16% $0.4598 3,225,429 15 Feb 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SRGA Warrants (right to buy) Purchase $32.61 +326,088 +74% $0.000100* 765,186 15 Feb 2022 Common Stock 326,088 $0.6000 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Total shares includes 17,985 shares purchased under the Company's Employee Stock Purchase Plan on December 31, 2021, which is exempt under Rule 16b-3(c).